Surveilens Epidemiologi HIV/AIDS di Rumah Sakit Pemerintah di Jakarta Selatan pada 2005

  • AGUS PURWANGGANA UNIVERSITAS PANCASILA
  • ENDANG POEDJININGSIH UNIVERSITAS PANCASILA
  • MUNIRO MUNIRO UNIVERSITAS PANCASILA

Abstract

HIV/AIDS has become a pandemic disease Which hits the Whole World including Indonesia. Antiretroviral (ARV) drugs are drugs pursuing HIV replication. A Government Hospital in South Jakarta is among hospitals that accept training on Voluntary Counseling and Testing (VCT) by the Department of Health, Republic of Indonesia, and has been a reference hospital for the medication of HIV/AIDS and its associated opportunistic infection in people With HIV/AIDS. This epidemiologic surveillance was conducted to find out proportion number, Case Fatality Rate (CFR), incidence rate and prevalence rate of all incidents related to HIV/AIDS. Data collection for people with HIV/AIDS was done through drug counseling cards, medical records and the laboratory examination results, and data analysis Was performed using Stata 7.0 software. Antiretroviral diugs often used in the Government Hospital in South Jakarta were Duviral-Neviral, Duviral-Evafir and Hiviral-Stavudin-Evahr. The results of this study show that the goals of the surveilance conducted can be achieved except for the number of incidence. Among 397 patients suspected to have HIV/AIDS, 324 patients had risk factor of HIV/AIDS, 240 patients were diagnosed positive HIV 290 patients Were severed with opportunistic infections, and 104 patients died.

References

1. Diambil dari: http://www.petra.ac.id/science/aids/aidsba.htm. Diakses pada tanggal 23 September 2005.

2. Diambil dari: http://www.ppk.Iipi.go.id/informasi/berita/berita detail.asp. Diakses pada tanggal 23 September 2005 .

3. Djauzi S, Savitri AV Pengobatan ARV pada infeksi HIV/AIDS indikasi dan pilihan terapi. Majalah Kedokteran Indonesia. 2002.52(3): 103-6.

4. Djauzi S, Zubairi D. Penatalaksanaan infeksi HIV di pelayanan kesehatan dasar. Edisi 2. Jakarta: FKUI; 2003.
5. Departemen Kesehatan Republik Indonesia. Pedoman nasional perawatan, dukungan dan pengobatan bagi ODHA. Jakarta: Direktorat Jenderal Pemberantasan Penyakit Menular dan Penyehatan Lingkungan; 2003.

6. Djauzi S, Ihsanil H. Pendekatan klinis infeksi oportunistik serebrai pada HIV/AIDS. Majalah Kedokteran Indonesia. 2003.53(8):303-7.

7. Departemen Kesehatan Republik Indonesia. Pedoman nasional terapi antiretroviral. Jakarta: Direktorat Jenderal Pemberantasan Penyakit Menular Penyehatan Lingkungan; 2004.

8. Departemen Kesehatan Republik Indonesia. Pedoman monitoring pasien untuk perawatan HIV dan terapi ARV Jakarta: Direktorat Jenderal Pemberantasan Penyakit Menular dan Penyehatan Lingkungan; 2005.

9. Subaris H, Aritonang, Handoko T, Bondan P, Sri A, Winarti. Manajemen epidemiologi. Yogyakarta Media Pressindo bekerjasama dengan Pusat Studi Epidemiologi Politeknik Kesehatan; 2004.

10. Tierney M, Lawrence. Current medical diagnosis and treatment. 44th ed. 2005. p. 1274-1303.
Published
2009-04-30
How to Cite
PURWANGGANA, AGUS; POEDJININGSIH, ENDANG; MUNIRO, MUNIRO. Surveilens Epidemiologi HIV/AIDS di Rumah Sakit Pemerintah di Jakarta Selatan pada 2005. JURNAL ILMU KEFARMASIAN INDONESIA, [S.l.], v. 7, n. 1, p. 49-55, apr. 2009. ISSN 2614-6495. Available at: <http://jifi.farmasi.univpancasila.ac.id/index.php/jifi/article/view/397>. Date accessed: 25 apr. 2024.
Citation Formats
Issue
Vol 7 No 1 (2009): JIFI
Section
Articles
License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.